Group items tagged

Best Practices (BPs), while employed in a variety of industries, is especially valuable in the growing drug/device (DD) combination products industry. Read the article to know how drug and device start-ups get the jump on the competition by employment of best practices.

At Pharma CI Conference 2015 in New Jersey, Best Practices, LLC's CEO, Chris Bogan discussed the topic: Blockbuster Drugs Launch Evolution: Mapping Market - Entry Changes That Cause New Products to Stumble or Soar.

Watch Best Practices, LLC video on medical affairs role, transparent management requirement, organizational structure and responsibility in kol management.

Join the medical affairs consortium and stay connected with the top practice leaders in pharma medical affairs. Discuss on healthcare challenges and share your experience & views with other members.

This report summary is an overview of the full report published by Best Practices, LLC. The report includes insights and information about the new pharmaceutical drugs launch spend in medical affairs in the US market.